Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N 01801: A host strategy to present featured peptides

Journal of Virology

Volumn 85, Issue 12, 2011, Pages 6038-6048

  Li, Xin ^a,b   Liu, Jun ^b,c   Qi, Jianxun ^b   Gao, Feng ^d,e   Li, Qirun ^a   Li, Xiaoying ^a   Zhang, Nianzhi ^a   Xia, Chun ^a,b   Gao, George F ^a,b,c,f  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d INSTITUTE OF BIOPHYSICS   (China)

^e SICHUAN UNIVERSITY   (China)

^f INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLPROLYLALANYLPROLYLISOLEUCYLSERYLTHREONYLMETHIONYLISOLEUCINE; ASPARAGINYLPROLYLMETHIONYLLYSYLALANYLLEUCYLTYROSYLPROLYLISOLEUCINE; EPITOPE; ISOLEUCYLPROLYLALANYLTYROSYLGLYCYLVALYLLEUCYLTHREONYLISOLEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; T LYMPHOCYTE RECEPTOR; THREONYLPROLYLGLYCYLALANYLTHREONYLTHREONYLPROLYLVALINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CATTLE PLAGUE VIRUS; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; COW; CRYSTAL STRUCTURE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS CELL INTERACTION; X RAY DIFFRACTION;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; CRYSTALLOGRAPHY, X-RAY; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RINDERPEST VIRUS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC;

BOVINAE; RINDERPEST VIRUS;

EID: 79958217989     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00030-11     Document Type: Article

References (64)

1. Achour, A., et al. 2006. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human β2-microglobulin. J. Mol. Biol. 356:382-396.
2. Adams, P. D., et al. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58:1948-1954.
3. Ahmed, N., and S. Gottschalk. 2009. How to design effective vaccines: lessons from an old success story. Expert Rev. Vaccines 8:543-546.
4. Amorena, B., and W. H. Stone. 1978. Serologically defined (SD) locus in cattle. Science 201:159-160.
5. Babiuk, S., et al. 2007. BoLA class I allele diversity and polymorphism in a herd of cattle. Immunogenetics 59:167-176.
6. Bensaid, A., et al. 1991. Identification of expressed bovine class I MHC genes at two loci and demonstration of physical linkage. Immunogenetics 33:247- 254.
7. Birtley, J. R., et al. 2005. Crystal structure of foot-and-mouth disease virus 3C protease.New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280:11520-11527.
8. Chen, W., et al. 2010. Crystal structure of a bony fish β2-microglobulin: insights into the evolutionary origin of immunoglobulin superfamily constant molecules. J. Biol. Chem. 285:22505-22512.
9. Chen, Y., Y. Shi, H. Cheng, Y. Q. An, and G. F. Gao. 2009. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands. IUBMB Life 61:579-590.
10. Chu, F., et al. 2007. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape. J. Immunol. 178: 944-952.
11. Ciatto, C., et al. 2001. Zooming in on the hydrophobic ridge of H-2Db: implications for the conformational variability of bound peptides. J. Mol. Biol. 312:1059-1071.
12. Cole, D. K., et al. 2006. Crystal structure of HLA-A*2402 complexed with a telomerase peptide. Eur. J. Immunol. 36:170-179.
13. Davies, C. J., et al. 1994. Polymorphism of bovine MHC class I genes. Joint report of the Fifth International Bovine Lymphocyte Antigen (BoLA) Workshop, Interlaken, Switzerland, 1 August 1992. Eur. J. Immunogenet. 21:239- 258.
14. De Groot, A. S., et al. 2003. T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11. Int. J. Parasitol. 33:641-653.
15. Ellis, S. 2004. The cattle major histocompatibility complex: is it unique? Vet. Immunol. Immunopathol. 102:1-8.
16. Ellis, S. A., and K. T. Ballingall. 1999. Cattle MHC: evolution in action? Immunol. Rev. 167:159-168.
17. Ellis, S. A., K. A. Staines, and W. I. Morrison. 1996. cDNA sequence of cattle MHC class I genes transcribed in serologically defined haplotypes A18 and A31. Immunogenetics 43:156-159.
18. Ellis, S. A., K. A. Staines, M. J. Stear, E. J. Hensen, and W. I. Morrison. 1998. DNA typing for BoLA class I using sequence-specific primers (PCRSSP). Eur. J. Immunogenet. 25:365-370.
19. Emsley, P., B. Lohkamp, W. G. Scott, and K. Cowtan. 2004. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486-501.
20. Ennis, P. D., A. P. Jackson, and P. Parham. 1988. Molecular cloning of bovine class I MHC cDNA. J. Immunol. 141:642-651.
21. Falk, K., et al. 1995. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behcet's disease. Int. Immunol. 7:223-228.
22. Fries, R., R. Hediger, and G. Stranzinger. 1986. Tentative chromosomal localization of the bovine major histocompatibility complex by in situ hybridization. Anim. Genet. 17:287-294.
23. Gilbert, N. 2009. Cattle disease faces total wipeout. Nature 462:709.
24. Gouet, P., X. Robert, and E. Courcelle. 2003. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31:3320-3323.
25. Gras, S., L. Kjer-Nielsen, S. R. Burrows, J. McCluskey, and J. Rossjohn. 2008. T-cell receptor bias and immunity. Curr. Opin. Immunol. 20:119-125.
26. Guzman, E., G. Taylor, B. Charleston, M. A. Skinner, and S. A. Ellis. 2008. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-andmouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J. Gen. Virol. 89:667-675.
27. Hegde, N. R., M. S. Deshpande, D. L. Godson, L. A. Babiuk, and S. Srikumaran. 1999. Bovine lymphocyte antigen-A11-specific peptide motif as a means to identify cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1. Viral Immunol. 12:149-161.
28. Hegde, N. R., et al. 1995. Peptide motif of the cattle MHC class I antigen BoLA-A11. Immunogenetics 42:302-303.
29. Holmes, E. C., A. F. Roberts, K. A. Staines, and S. A. Ellis. 2003. Evolution of major histocompatibility complex class I genes in Cetartiodactyls. Immunogenetics 55:193-202.
30. Laskowski, R. A., D. S. Moss, and J. M. Thornton. 1993. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231:1049-1067.
31. Liu, J., et al. 2010. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J. Infect. Dis. 202:1171-1180.
32. Liu, J., et al. 2010. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Virol. 84:11849-11857.
33. Liu, J., S. Zhang, S. Tan, B. Zhen, and G. F. Gao. 2011. Revival of the identification of CTL epitopes for immunological diagnosis, therapy and vaccine development. Exp. Biol. Med. doi:10.1258/ebm.2010.010278.
34. Macdonald, I. K., et al. 2010. MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors. PLoS Pathog. 6:e1001149.
35. Maenaka, K., et al. 2000. Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J. Immunol. 165:3260-3267.
36. Markel, H. 2005. The search for effective HIV vaccines. N. Engl. J. Med. 353:753-757.
37. Maryanski, J. L., et al. 1997. The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized. Hum. Immunol. 54:117-128.
38. b molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. J. Mol. Biol. 345:1099-1110.
39. Messaoudi, I., J. A. Guevara Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich. 2002. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797-1800.
40. Normile, D. 2008. Rinderpest. Driven to extinction. Science 319:1606-1609.
41. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
42. Parkin, S., and H. Hope. 1998. Macromolecular cryocrystallography: cooling, mounting, storage and transportation of crystals. J. Appl. Crystallogr. 31: 945-953.
43. Pedersen, L. O., et al. 1995. The interaction of β2-microglobulin (β2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse β2m. Eur. J. Immunol. 25:1609-1616.
44. Price, D. A., et al. 2004. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21:793-803.
45. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228.
46. Rodriguez, L. L., and M. J. Grubman. 2009. Foot and mouth disease virus vaccines. Vaccine 27(Suppl. 4):D90-D94.
47. Russell, G. C., R. A. Oliver, and S. M. Sawhney. 1996. Cloning, transfection, and DNA sequence of a second gene from the BoLA-A11 haplotype. Immunogenetics 44:315-318.
48. Sawhney, S. M., et al. 1995. Transfection, expression, and DNA sequence of a gene encoding a BoLA-A11 antigen. Immunogenetics 41:246-250.
49. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463-493.
50. Shields, M. J., L. E. Moffat, and R. K. Ribaudo. 1998. Functional comparison of bovine, murine, and human β2-microglobulin: interactions with murine MHC I molecules. Mol. Immunol. 35:919-928.
51. Sinnathamby, G., S. Seth, R. Nayak, and M. S. Shaila. 2004. Cytotoxic T cell epitope in cattle from the attachment glycoproteins of rinderpest and peste des petits ruminants viruses. Viral Immunol. 17:401-410.
52. + T cells without selection of higher affinity TCR. Nat. Immunol. 2:711- 717.
53. Sliz, P., et al. 2001. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J. Immunol. 167:3276-3284.
54. Subbarao, K., B. R. Murphy, and A. S. Fauci. 2006. Development of effective vaccines against pandemic influenza. Immunity 24:5-9.
55. Sun, Y., et al. 2010. Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses. J. Gen. Virol. 91:919-930.
56. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
57. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6:883- 894.
58. + T cell populations. Nat. Immunol. 6:382-389.
59. Tynan, F. E., et al. 2005. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J. Biol. Chem. 280:23900-23909.
60. Tynan, F. E., et al. 2005. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat. Immunol. 6:1114- 1122.
61. Tynan, F. E., et al. 2007. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8:268-276.
62. Vordermeier, H. M., et al. 2009. Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model. Clin. Vaccine Immunol. 16:1443-1448.
63. + T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23:651-682.
64. d complexed with an HBV-core nonapeptide. Acta Crystallogr. D Biol. Crystallogr. 60:1473-1475